Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-002576
Filing Date
2014-06-20
Accepted
2014-06-20 17:00:38
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aldr-10q_20140331.htm 10-Q 1180586
2 EX-31.1 aldr-ex31_201403316.htm EX-31 13332
3 EX-31.2 aldr-ex31_201403317.htm EX-31 13328
4 EX-32.1 aldr-ex32_201403318.htm EX-32 10040
  Complete submission text file 0001564590-14-002576.txt   3246873

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aldr-20140331.xml EX-101.INS 308259
6 XBRL TAXONOMY EXTENSION SCHEMA aldr-20140331.xsd EX-101.SCH 20114
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldr-20140331_cal.xml EX-101.CAL 25293
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldr-20140331_def.xml EX-101.DEF 130913
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldr-20140331_lab.xml EX-101.LAB 166661
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldr-20140331_pre.xml EX-101.PRE 149906
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Filer) CIK: 0001423824 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36431 | Film No.: 14933472
SIC: 2834 Pharmaceutical Preparations